NASDAQ:TVTY - Tivity Health Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$38.50 +0.25 (+0.65 %)
(As of 05/27/2018 04:00 PM ET)
Previous Close$38.50
Today's Range$37.95 - $38.85
52-Week Range$29.95 - $48.50
Volume424,618 shs
Average Volume559,346 shs
Market Capitalization$1.54 billion
P/E Ratio21.75
Dividend YieldN/A
Beta0.31

About Tivity Health (NASDAQ:TVTY)

Tivity Health logoTivity Health, Inc. provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers. It also provides health plans through WholeHealth Living program; and health services, such as chiropractic care, acupuncture, physical therapy, occupational therapy, speech therapy, and others. The company was formerly known as Healthways, Inc. and changed its name to Tivity Health, Inc. in January 2017. Tivity Health, Inc. was founded in 1981 and is headquartered in Franklin, Tennessee.

Receive TVTY News and Ratings via Email

Sign-up to receive the latest news and ratings for TVTY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryHealth Care Services
SectorMedical
SymbolNASDAQ:TVTY
CUSIP42224510
Phone615-614-4929

Debt

Debt-to-Equity RatioN/A
Current Ratio0.70
Quick Ratio0.70

Price-To-Earnings

Trailing P/E Ratio21.75
Forward P/E Ratio17.82
P/E Growth1.62

Sales & Book Value

Annual Sales$556.94 million
Price / Sales2.76
Cash Flow$2.1629 per share
Price / Cash17.80
Book Value$7.39 per share
Price / Book5.21

Profitability

EPS (Most Recent Fiscal Year)$1.68
Net Income$63.71 million
Net Margins12.33%
Return on Equity28.62%
Return on Assets11.51%

Miscellaneous

Employees475
Outstanding Shares39,880,000

Tivity Health (NASDAQ:TVTY) Frequently Asked Questions

What is Tivity Health's stock symbol?

Tivity Health trades on the NASDAQ under the ticker symbol "TVTY."

How were Tivity Health's earnings last quarter?

Tivity Health Inc (NASDAQ:TVTY) posted its quarterly earnings data on Monday, April, 23rd. The company reported $0.49 EPS for the quarter, meeting the Zacks' consensus estimate of $0.49. The company had revenue of $149.90 million for the quarter, compared to analyst estimates of $154.32 million. Tivity Health had a net margin of 12.33% and a return on equity of 28.62%. The company's quarterly revenue was up 6.3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.42 EPS. View Tivity Health's Earnings History.

When is Tivity Health's next earnings date?

Tivity Health is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Tivity Health.

What guidance has Tivity Health issued on next quarter's earnings?

Tivity Health issued an update on its FY18 earnings guidance on Monday, April, 23rd. The company provided EPS guidance of $2.12-2.20 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.16. The company issued revenue guidance of $607-625 million, compared to the consensus revenue estimate of $617.52 million.

What price target have analysts set for TVTY?

8 analysts have issued twelve-month price targets for Tivity Health's shares. Their forecasts range from $41.00 to $53.00. On average, they anticipate Tivity Health's stock price to reach $47.3750 in the next year. View Analyst Ratings for Tivity Health.

What are Wall Street analysts saying about Tivity Health stock?

Here are some recent quotes from research analysts about Tivity Health stock:
  • 1. According to Zacks Investment Research, "Tivity Health, Inc. provides health management services. The company offers services which include chiropractic services, physical therapy, occupational therapy, speech therapy, acupuncture, massage and complementary and alternative medicine services. Its network comprises SilverSneakers(R), Prime(R) Fitness and WholeHealth Living (TM). Tivity Health, Inc., formerly known as Healthways, Inc., is based in Franklin, Tennessee. " (4/26/2018)
  • 2. Cantor Fitzgerald analysts commented, "Mixed 1Q18 results. Revenue of $150 million (+6.4% y/y) was below our estimate of $156 million and consensus of $154 million. Adjusted EBITDA margins remained healthy at 22.1%. Adjusted EPS of $0.49 were in line with consensus but below our estimate of $0.52." (4/23/2018)

Who are some of Tivity Health's key competitors?

Who are Tivity Health's key executives?

Tivity Health's management team includes the folowing people:
  • Mr. Donato J. Tramuto, CEO & Director (Age 61)
  • Mr. Glenn Hargreaves, Chief Accounting Officer & Controller (Age 51)
  • Ms. Mary S. Flipse, Chief Legal Officer (Age 51)
  • Mr. Adam C. Holland, Chief Financial Officer (Age 39)
  • Mr. Paul Edmisten, Chief Information Officer

Has Tivity Health been receiving favorable news coverage?

News stories about TVTY stock have trended somewhat positive recently, Accern reports. Accern identifies positive and negative press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Tivity Health earned a coverage optimism score of 0.18 on Accern's scale. They also assigned press coverage about the company an impact score of 45.33 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future.

Who are Tivity Health's major shareholders?

Tivity Health's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.70%), Neuberger Berman Group LLC (5.84%), Dimensional Fund Advisors LP (3.93%), Eagle Asset Management Inc. (3.82%), American Century Companies Inc. (3.19%) and Hood River Capital Management LLC (3.10%). Company insiders that own Tivity Health stock include Conan Laughlin, Donato Tramuto, Glenn Hargreaves, Mary Flipse, Mary Jane England and Robert J Greczyn Jr. View Institutional Ownership Trends for Tivity Health.

Which major investors are selling Tivity Health stock?

TVTY stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Wells Fargo & Company MN, Dimensional Fund Advisors LP, Russell Investments Group Ltd., Mckinley Capital Management LLC Delaware, JPMorgan Chase & Co., Comerica Bank and Algert Global LLC. Company insiders that have sold Tivity Health company stock in the last year include Conan Laughlin, Donato Tramuto, Glenn Hargreaves and Mary Flipse. View Insider Buying and Selling for Tivity Health.

Which major investors are buying Tivity Health stock?

TVTY stock was acquired by a variety of institutional investors in the last quarter, including Monarch Partners Asset Management LLC, Van Berkom & Associates Inc., Eagle Asset Management Inc., Point72 Asset Management L.P., Nuveen Asset Management LLC, Freestone Capital Holdings LLC, Franklin Resources Inc. and Fort Washington Investment Advisors Inc. OH. Company insiders that have bought Tivity Health stock in the last two years include Donato Tramuto and Robert J Greczyn Jr. View Insider Buying and Selling for Tivity Health.

How do I buy shares of Tivity Health?

Shares of TVTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tivity Health's stock price today?

One share of TVTY stock can currently be purchased for approximately $38.50.

How big of a company is Tivity Health?

Tivity Health has a market capitalization of $1.54 billion and generates $556.94 million in revenue each year. The company earns $63.71 million in net income (profit) each year or $1.68 on an earnings per share basis. Tivity Health employs 475 workers across the globe.

How can I contact Tivity Health?

Tivity Health's mailing address is 701 Cool Springs Boulevard, Franklin TN, 37067. The company can be reached via phone at 615-614-4929 or via email at [email protected]


MarketBeat Community Rating for Tivity Health (TVTY)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  256 (Vote Outperform)
Underperform Votes:  285 (Vote Underperform)
Total Votes:  541
MarketBeat's community ratings are surveys of what our community members think about Tivity Health and other stocks. Vote "Outperform" if you believe TVTY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TVTY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Tivity Health (NASDAQ:TVTY) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
8 Wall Street analysts have issued ratings and price targets for Tivity Health in the last 12 months. Their average twelve-month price target is $47.3750, suggesting that the stock has a possible upside of 23.05%. The high price target for TVTY is $53.00 and the low price target for TVTY is $41.00. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.882.882.862.86
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $47.3750$47.3750$47.1429$45.4286
Price Target Upside: 23.05% upside20.09% upside23.90% upside43.76% upside

Tivity Health (NASDAQ:TVTY) Consensus Price Target History

Price Target History for Tivity Health (NASDAQ:TVTY)

Tivity Health (NASDAQ:TVTY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/24/2018Piper Jaffray CompaniesReiterated RatingBuy$49.00HighView Rating Details
4/23/2018Cantor FitzgeraldReiterated RatingBuy$53.00HighView Rating Details
2/23/2018Barrington ResearchBoost Price TargetOutperform ➝ Outperform$40.00 ➝ $47.00HighView Rating Details
2/23/2018Chardan CapitalReiterated RatingNeutral ➝ Neutral$44.00 ➝ $41.00HighView Rating Details
11/1/2017OppenheimerBoost Price TargetOutperform$47.00 ➝ $50.00N/AView Rating Details
10/27/2017SunTrust BanksSet Price TargetBuy$50.00N/AView Rating Details
9/25/2017Jefferies GroupReiterated RatingBuy$46.00LowView Rating Details
6/23/2017UBSBoost Price TargetBuy$37.00 ➝ $43.00LowView Rating Details
8/22/2016BarclaysUpgradeUnderweight ➝ Equal Weight$12.00 ➝ $27.00N/AView Rating Details
8/10/2016FBR & CoBoost Price TargetOutperform$16.00 ➝ $21.00N/AView Rating Details
(Data available from 5/27/2016 forward)

Earnings

Tivity Health (NASDAQ:TVTY) Earnings History and Estimates Chart

Earnings by Quarter for Tivity Health (NASDAQ:TVTY)

Tivity Health (NASDAQ:TVTY) Earnings Estimates

2018 EPS Consensus Estimate: $2.07
2019 EPS Consensus Estimate: $2.44
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20185$0.42$0.52$0.49
Q2 20186$0.50$0.55$0.53
Q3 20185$0.41$0.60$0.54
Q4 20186$0.40$0.57$0.51
Q1 20194$0.53$0.57$0.56
Q2 20193$0.60$0.62$0.61
Q3 20193$0.61$0.69$0.64
Q4 20192$0.59$0.66$0.63

Tivity Health (NASDAQ TVTY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/25/2018$0.53N/AView Earnings Details
4/23/2018Q1 2018$0.49$0.49$154.32 million$149.90 millionViewListenView Earnings Details
2/22/2018Q4 2017$0.32$0.41$138.22 million$139.40 millionViewListenView Earnings Details
10/26/2017Q3 2017$0.36$0.46$137.95 million$137.70 millionViewN/AView Earnings Details
7/27/2017Q2 2017$0.38$0.4080$138.15 million$138.90 millionViewN/AView Earnings Details
4/27/2017Q1 2017$0.34$0.42$136.28 million$141.00 millionViewN/AView Earnings Details
2/23/2017Q416$0.30$0.35$125.18 million$124.93 millionViewN/AView Earnings Details
11/1/2016Q3$0.52$0.30$124.71 million$125.00 millionViewListenView Earnings Details
8/9/2016Q216$0.01$0.54$186.88 million$125.00 millionViewListenView Earnings Details
4/28/2016Q1($0.02)($0.08)$185.68 million$189.20 millionViewListenView Earnings Details
2/25/2016Q4($0.08)($0.04)$180.49 million$186.28 millionViewListenView Earnings Details
10/29/2015Q315$0.01$0.14$190.62 million$196.40 millionViewListenView Earnings Details
7/23/2015Q215($0.09)$0.11$191.20 million$198.10 millionViewListenView Earnings Details
4/23/2015Q115($0.03)($0.05)$193.04 million$189.90 millionViewListenView Earnings Details
2/24/2015Q414$0.19$0.25$198.50 million$199.10 millionViewListenView Earnings Details
10/23/2014Q314$0.08$0.08$186.80 million$185.70 millionViewListenView Earnings Details
7/23/2014Q214($0.01)$179.53 million$180.60 millionViewListenView Earnings Details
4/24/2014Q114($0.12)($0.07)$177.13 million$176.80 millionViewListenView Earnings Details
2/13/2014Q413$0.13($0.12)$174.50 million$169.20 millionViewListenView Earnings Details
10/24/2013Q313$0.13$0.05$185.74 million$166.60 millionViewListenView Earnings Details
7/24/2013Q2 2013($0.05)($0.03)$170.30 million$162.27 millionViewListenView Earnings Details
4/18/2013Q1 2013($0.15)($0.12)$162.81 million$165.20 millionViewListenView Earnings Details
2/7/2013Q4 2012$0.06$0.05$175.08 million$175.20 millionViewListenView Earnings Details
10/18/2012$0.13$0.15ViewN/AView Earnings Details
7/24/2012$0.06$0.15ViewN/AView Earnings Details
4/24/2012Q1 2012($0.08)ViewN/AView Earnings Details
2/15/2012$0.33$0.27ViewN/AView Earnings Details
10/24/2011$0.27$0.28ViewN/AView Earnings Details
7/21/2011$0.17$0.17ViewN/AView Earnings Details
4/26/2011$0.20$0.12ViewN/AView Earnings Details
2/15/2011$0.26$0.25ViewN/AView Earnings Details
10/21/2010Q3 2010$0.28$0.30ViewN/AView Earnings Details
7/22/2010Q2 2010$0.27$0.29ViewN/AView Earnings Details
4/22/2010Q1 2010$0.27$0.27ViewN/AView Earnings Details
2/16/2010Q4 2009$0.22$0.22ViewN/AView Earnings Details
10/22/2009Q3 2009$0.23$0.26ViewN/AView Earnings Details
7/23/2009Q2 2009$0.24$0.26ViewN/AView Earnings Details
4/20/2009Q1 2009$0.25$0.30ViewN/AView Earnings Details
1/8/2009Q4 2008$0.34$0.37ViewN/AView Earnings Details
10/16/2008Q3 2008$0.50$0.49ViewN/AView Earnings Details
6/18/2008Q2 2008$0.38$0.41ViewN/AView Earnings Details
3/18/2008Q1 2008$0.34$0.33ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Tivity Health (NASDAQ:TVTY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Tivity Health (NASDAQ TVTY) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 8.42%
Insider Trading History for Tivity Health (NASDAQ:TVTY)
Institutional Ownership by Quarter for Tivity Health (NASDAQ:TVTY)

Tivity Health (NASDAQ TVTY) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/1/2018Donato TramutoCEOSell20,000$35.37$707,400.00149,596View SEC Filing  
4/2/2018Donato TramutoCEOSell20,000$39.30$786,000.00View SEC Filing  
3/1/2018Donato TramutoCEOSell20,000$38.53$770,600.00189,596View SEC Filing  
11/21/2017Conan LaughlinDirectorSell140,000$34.90$4,886,000.00View SEC Filing  
11/17/2017Conan LaughlinDirectorSell490,000$34.34$16,826,600.00View SEC Filing  
11/15/2017Conan LaughlinDirectorSell115,087$33.87$3,897,996.69View SEC Filing  
11/6/2017Conan LaughlinDirectorSell120,000$47.52$5,702,400.00View SEC Filing  
11/3/2017Mary FlipseInsiderSell5,000$48.11$240,550.0045,167View SEC Filing  
11/2/2017Glenn HargreavesCAOSell5,805$45.15$262,095.7544,448View SEC Filing  
9/26/2017Glenn HargreavesInsiderSell7,137$40.00$285,480.0052,180View SEC Filing  
9/25/2017Mary FlipseInsiderSell7,808$39.00$304,512.0057,975View SEC Filing  
8/21/2017Glenn HargreavesInsiderSell23,448$37.78$885,865.4462,211View SEC Filing  
8/18/2017Mary FlipseInsiderSell14,020$37.03$519,160.6061,167View SEC Filing  
8/11/2017Mary FlipseInsiderSell1,340$37.32$50,008.8075,187View SEC Filing  
8/4/2017Glenn HargreavesInsiderSell21,105$38.00$801,990.0059,077View SEC Filing  
8/1/2017Conan LaughlinDirectorSell1,750,000$37.90$66,325,000.00View SEC Filing  
5/3/2017Mary Jane EnglandDirectorSell1,763$31.95$56,327.8519,453View SEC Filing  
4/3/2017Mary Jane EnglandDirectorSell2,674$29.05$77,679.7021,216View SEC Filing  
3/3/2017Mary Jane EnglandDirectorSell2,340$28.60$66,924.0023,890View SEC Filing  
3/1/2017Conan LaughlinInsiderSell2,000,000$28.30$56,600,000.00View SEC Filing  
2/3/2017Mary Jane EnglandDirectorSell2,343$25.55$59,863.6526,230View SEC Filing  
1/3/2017Mary Jane EnglandDirectorSell2,298$22.40$51,475.2028,573View SEC Filing  
11/18/2016Mary Jane EnglandDirectorSell3,600$22.26$80,136.0030,871View SEC Filing  
11/4/2016Donato TramutoCEOBuy5,060$19.95$100,947.00275,442View SEC Filing  
11/4/2016Robert J Greczyn JrDirectorBuy5,000$19.55$97,750.0030,578View SEC Filing  
8/26/2016Mary Jane EnglandDirectorSell3,816$24.78$94,560.4839,068View SEC Filing  
11/13/2015Conan LaughlinDirectorBuy47,600$12.65$602,140.006,203View SEC Filing  
11/12/2015Conan LaughlinDirectorBuy252,400$12.49$3,152,476.006,203View SEC Filing  
11/5/2015Conan LaughlinDirectorBuy350,000$11.51$4,028,500.006,203View SEC Filing  
11/3/2015Donato TramutoCEOBuy8,740$11.47$100,247.80304,186View SEC Filing  
11/3/2015Lee ShapiroDirectorBuy4,359$11.42$49,779.7810,562View SEC Filing  
7/31/2014North Tide Capital, LlcMajor ShareholderSell100,000$17.29$1,729,000.00View SEC Filing  
12/18/2013North Tide Capital, Llcmajor shareholderBuy140,000$14.11$1,975,400.00View SEC Filing  
11/7/2013Donato TramutoDirectorBuy4,200$11.77$49,434.004,200View SEC Filing  
10/29/2013Alfred LumsdaineCFOBuy5,000$10.80$54,000.00View SEC Filing  
8/14/2013Alfred LumsdaineCFOSell9,425$18.64$175,682.0017,821View SEC Filing  
8/14/2013Ben Leedle, Jr.CEOSell293,984$18.68$5,491,621.12201,814View SEC Filing  
6/3/2013Jay C BisgardDirectorSell4,869$14.58$70,990.02View SEC Filing  
5/17/2013Jay C BisgardDirectorSell2,039$14.50$29,565.50View SEC Filing  
5/14/2013Jay C BisgardDirectorSell18,343$14.51$266,156.93View SEC Filing  
5/9/2013John W BallantineDirectorSell27,400$14.02$384,148.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Tivity Health (NASDAQ TVTY) News Headlines

Source:
DateHeadline
$152.59 Million in Sales Expected for Tivity Health (TVTY) This Quarter$152.59 Million in Sales Expected for Tivity Health (TVTY) This Quarter
www.americanbankingnews.com - May 24 at 4:20 AM
Tivity Health (TVTY) Expected to Announce Earnings of $0.53 Per ShareTivity Health (TVTY) Expected to Announce Earnings of $0.53 Per Share
www.americanbankingnews.com - May 22 at 11:26 AM
Financial Contrast: Tivity Health (TVTY) and Caladrius Biosciences (CLBS)Financial Contrast: Tivity Health (TVTY) and Caladrius Biosciences (CLBS)
www.americanbankingnews.com - May 11 at 9:29 PM
Davita (DVA) vs. Tivity Health (TVTY) Head to Head ComparisonDavita (DVA) vs. Tivity Health (TVTY) Head to Head Comparison
www.americanbankingnews.com - May 8 at 9:10 PM
Head-To-Head Survey: Tivity Health (TVTY) and Caladrius Biosciences (CLBS)Head-To-Head Survey: Tivity Health (TVTY) and Caladrius Biosciences (CLBS)
www.americanbankingnews.com - May 6 at 9:16 PM
Tivity Health (TVTY) Receives Average Recommendation of "Buy" from AnalystsTivity Health (TVTY) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 6 at 11:38 AM
$0.53 Earnings Per Share Expected for Tivity Health (TVTY) This Quarter$0.53 Earnings Per Share Expected for Tivity Health (TVTY) This Quarter
www.americanbankingnews.com - May 5 at 3:24 AM
Tivity Health (TVTY) CEO Donato Tramuto Sells 20,000 SharesTivity Health (TVTY) CEO Donato Tramuto Sells 20,000 Shares
www.americanbankingnews.com - May 2 at 1:24 PM
Edited Transcript of TVTY earnings conference call or presentation 23-Apr-18 9:00pm GMTEdited Transcript of TVTY earnings conference call or presentation 23-Apr-18 9:00pm GMT
finance.yahoo.com - April 27 at 9:34 AM
Tivity Health (TVTY) Downgraded by Zacks Investment Research to "Hold"Tivity Health (TVTY) Downgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - April 26 at 1:08 PM
SunTrust Banks Analysts Cut Earnings Estimates for Tivity Health (TVTY)SunTrust Banks Analysts Cut Earnings Estimates for Tivity Health (TVTY)
www.americanbankingnews.com - April 26 at 10:42 AM
Barrington Research Analysts Decrease Earnings Estimates for Tivity Health (TVTY)Barrington Research Analysts Decrease Earnings Estimates for Tivity Health (TVTY)
www.americanbankingnews.com - April 26 at 10:03 AM
Tivity Health (TVTY) Expected to Earn FY2018 Earnings of $2.14 Per ShareTivity Health (TVTY) Expected to Earn FY2018 Earnings of $2.14 Per Share
www.americanbankingnews.com - April 26 at 10:02 AM
Financial Survey: Tivity Health (TVTY) versus Fresenius Medical Care (FMS)Financial Survey: Tivity Health (TVTY) versus Fresenius Medical Care (FMS)
www.americanbankingnews.com - April 26 at 9:38 AM
Q2 2018 EPS Estimates for Tivity Health (TVTY) Cut by OppenheimerQ2 2018 EPS Estimates for Tivity Health (TVTY) Cut by Oppenheimer
www.americanbankingnews.com - April 26 at 8:44 AM
Barrington Research Analysts Boost Earnings Estimates for Tivity Health (TVTY)Barrington Research Analysts Boost Earnings Estimates for Tivity Health (TVTY)
www.americanbankingnews.com - April 25 at 9:50 AM
Tivity Health to Post FY2018 Earnings of $2.17 Per Share, Oppenheimer Forecasts (TVTY)Tivity Health to Post FY2018 Earnings of $2.17 Per Share, Oppenheimer Forecasts (TVTY)
www.americanbankingnews.com - April 25 at 9:27 AM
William Blair Equities Analysts Boost Earnings Estimates for Tivity Health (TVTY)William Blair Equities Analysts Boost Earnings Estimates for Tivity Health (TVTY)
www.americanbankingnews.com - April 25 at 9:27 AM
Q2 2018 Earnings Estimate for Tivity Health Issued By Jefferies Group (TVTY)Q2 2018 Earnings Estimate for Tivity Health Issued By Jefferies Group (TVTY)
www.americanbankingnews.com - April 25 at 8:28 AM
SunTrust Banks Weighs in on Tivity Healths Q3 2018 Earnings (TVTY)SunTrust Banks Weighs in on Tivity Health's Q3 2018 Earnings (TVTY)
www.americanbankingnews.com - April 25 at 8:06 AM
Q2 2018 EPS Estimates for Tivity Health Reduced by Analyst (TVTY)Q2 2018 EPS Estimates for Tivity Health Reduced by Analyst (TVTY)
www.americanbankingnews.com - April 25 at 7:36 AM
After-Hours Stock Movers 04/23: (SANM) (CDNS) (HSII) Higher; (EPZM) (TVTY) (CVNA) Lower (more...)After-Hours Stock Movers 04/23: (SANM) (CDNS) (HSII) Higher; (EPZM) (TVTY) (CVNA) Lower (more...)
www.streetinsider.com - April 24 at 4:58 PM
Tivity Health Q1 top line up 6%; earnings up 39%; cash flow up 313%Tivity Health Q1 top line up 6%; earnings up 39%; cash flow up 313%
seekingalpha.com - April 24 at 9:03 AM
Tivity Health, Inc. (TVTY) Reports In-Line Q1 EPS, Miss on Revenues; Offers FY18 EPS In-Line OutlookTivity Health, Inc. (TVTY) Reports In-Line Q1 EPS, Miss on Revenues; Offers FY18 EPS In-Line Outlook
www.streetinsider.com - April 24 at 9:03 AM
Tivity Healths (TVTY) CEO Donato Tramuto on Q1 2018 Results - Earnings Call TranscriptTivity Health's (TVTY) CEO Donato Tramuto on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - April 24 at 9:03 AM
Piper Jaffray Reiterates "Buy" Rating for Tivity Health (TVTY)Piper Jaffray Reiterates "Buy" Rating for Tivity Health (TVTY)
www.americanbankingnews.com - April 24 at 8:55 AM
Tivity Health (TVTY) Issues  Earnings Results, Meets EstimatesTivity Health (TVTY) Issues Earnings Results, Meets Estimates
www.americanbankingnews.com - April 24 at 7:52 AM
Tivity Health (TVTY) Rating Reiterated by Cantor FitzgeraldTivity Health (TVTY) Rating Reiterated by Cantor Fitzgerald
www.americanbankingnews.com - April 23 at 9:40 PM
Tivity Health (TVTY) Releases FY18 Earnings GuidanceTivity Health (TVTY) Releases FY18 Earnings Guidance
www.americanbankingnews.com - April 23 at 5:32 PM
Tivity Health EPS in-line, misses on revenueTivity Health EPS in-line, misses on revenue
seekingalpha.com - April 23 at 4:41 PM
Tivity Health: 1Q Earnings SnapshotTivity Health: 1Q Earnings Snapshot
finance.yahoo.com - April 23 at 4:41 PM
Tivity Health Reports First-Quarter 2018 Results and Affirms Financial GuidanceTivity Health Reports First-Quarter 2018 Results and Affirms Financial Guidance
finance.yahoo.com - April 23 at 4:41 PM
Analyzing Caladrius Biosciences (CLBS) & Tivity Health (TVTY)Analyzing Caladrius Biosciences (CLBS) & Tivity Health (TVTY)
www.americanbankingnews.com - April 22 at 9:14 AM
$153.72 Million in Sales Expected for Tivity Health (TVTY) This Quarter$153.72 Million in Sales Expected for Tivity Health (TVTY) This Quarter
www.americanbankingnews.com - April 19 at 1:52 AM
Financial Comparison: Caladrius Biosciences (CLBS) vs. Tivity Health (TVTY)Financial Comparison: Caladrius Biosciences (CLBS) vs. Tivity Health (TVTY)
www.americanbankingnews.com - April 18 at 3:20 AM
Zacks: Analysts Expect Tivity Health (TVTY) to Post $0.49 EPSZacks: Analysts Expect Tivity Health (TVTY) to Post $0.49 EPS
www.americanbankingnews.com - April 17 at 11:08 PM
Tivity Health (TVTY) Scheduled to Post Quarterly Earnings on TuesdayTivity Health (TVTY) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - April 17 at 4:13 AM
Tivity Health (TVTY) Stock Rating Lowered by BidaskClubTivity Health (TVTY) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 13 at 9:39 AM
Comparing Fresenius Medical Care (FMS) and Tivity Health (TVTY)Comparing Fresenius Medical Care (FMS) and Tivity Health (TVTY)
www.americanbankingnews.com - April 12 at 11:27 AM
Tivity Health (TVTY) Downgraded by Zacks Investment Research to "Sell"Tivity Health (TVTY) Downgraded by Zacks Investment Research to "Sell"
www.americanbankingnews.com - April 11 at 1:25 PM
Tivity Health (TVTY) Given Consensus Recommendation of "Buy" by BrokeragesTivity Health (TVTY) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - April 11 at 11:37 AM
Tivity Health CEO Donato Tramuto Named Chairman of Robert F. Kennedy Human Rights Leadership CouncilTivity Health CEO Donato Tramuto Named Chairman of Robert F. Kennedy Human Rights Leadership Council
finance.yahoo.com - April 9 at 4:42 PM
Tivity Health (TVTY) CEO Sells $786,000.00 in StockTivity Health (TVTY) CEO Sells $786,000.00 in Stock
www.americanbankingnews.com - April 4 at 10:39 PM
Catasys (CATS) versus Tivity Health (TVTY) Critical AnalysisCatasys (CATS) versus Tivity Health (TVTY) Critical Analysis
www.americanbankingnews.com - April 3 at 5:06 PM
Tivity Health (TVTY) Expected to Announce Quarterly Sales of $153.72 MillionTivity Health (TVTY) Expected to Announce Quarterly Sales of $153.72 Million
www.americanbankingnews.com - April 3 at 4:51 AM
Tivity Health (TVTY) Upgraded to Buy by Zacks Investment ResearchTivity Health (TVTY) Upgraded to Buy by Zacks Investment Research
www.americanbankingnews.com - April 2 at 8:04 PM
Tivity Health (TVTY) Given New $50.00 Price Target at OppenheimerTivity Health (TVTY) Given New $50.00 Price Target at Oppenheimer
www.americanbankingnews.com - April 2 at 10:44 AM
Tivity Health (TVTY) Stock Rating Lowered by ValuEngineTivity Health (TVTY) Stock Rating Lowered by ValuEngine
www.americanbankingnews.com - April 1 at 7:00 PM
Zacks: Brokerages Anticipate Tivity Health Inc (TVTY) Will Post Earnings of $0.49 Per ShareZacks: Brokerages Anticipate Tivity Health Inc (TVTY) Will Post Earnings of $0.49 Per Share
www.americanbankingnews.com - April 1 at 1:22 AM
Tivity Health (TVTY) Downgraded by BidaskClubTivity Health (TVTY) Downgraded by BidaskClub
www.americanbankingnews.com - March 30 at 5:40 PM

SEC Filings

Tivity Health (NASDAQ:TVTY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Tivity Health (NASDAQ:TVTY) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Tivity Health (NASDAQ TVTY) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.